PREGNANCY AND BIRTH HISTORIES AFTER 131-I THERAPY IN DIFFERENTIATED THYROID-CANCER (DTC)

被引：0
|
作者：
CASARA, D
RUBELLO, D
SALADINI, G
BORSATO, N
CHIERICHETTI, F
FERLIN, G
机构：
[1] PADUA HOSP,PADUA,ITALY
[2] CASTELFRANCO VENETO GEN HOSP,CASTELFRANCO VENE,ITALY
来源：
JOURNAL OF NUCLEAR MEDICINE | 1993年 / 34卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
引用
收藏
页码：P161 / P161
页数：1
相关论文
共 50 条
  • [41] SERUM THYROGLOBULIN AS A SUBSTITUTION OF I-131-SCANS IN FOLLOW-UP OF DIFFERENTIATED THYROID-CANCER
    REINERS, C
    ACTA ENDOCRINOLOGICA, 1983, 102 : 66 - 67
  • [42] THYROGLOBULIN LEVELS DURING I-131-TREATMENT AND FOLLOW-UP OF DIFFERENTIATED THYROID-CANCER
    MAIRA, G
    PAGLIAINI, R
    BESTAGNO, M
    JOURNAL OF NUCLEAR MEDICINE AND ALLIED SCIENCES, 1983, 27 (02): : 145 - 145
  • [43] Prognostic value of serial 131I scans in patinets with differentiated thyroid cancer after 131I therapy.
    Lu, HK
    Zhu, RS
    JOURNAL OF NUCLEAR MEDICINE, 2003, 44 (05) : 410P - 410P
  • [44] CANCER RISKS AFTER DIAGNOSTIC DOSES OF I-131 WITH SPECIAL REFERENCE TO THYROID-CANCER
    HOLM, LE
    CANCER DETECTION AND PREVENTION, 1991, 15 (01): : 27 - 30
  • [45] A SIMPLIFIED LOW IODINE DIET IN I-131 SCANNING AND THERAPY OF THYROID-CANCER
    LAKSHMANAN, M
    SCHAFFER, A
    ROBBINS, J
    REYNOLDS, J
    NORTON, J
    CLINICAL NUCLEAR MEDICINE, 1988, 13 (12) : 866 - 868
  • [46] THE INFLUENCE OF I-131 THERAPY IN THYROID-CANCER ON THE FUNCTION OF SALIVARY-GLANDS
    DELPRAT, CC
    HOEFNAGEL, CA
    MARCUSE, HR
    ACTA ENDOCRINOLOGICA, 1983, 102 : 73 - 74
  • [47] DELAYED 131-I FIRST TREATMENT AFTER SURGERY HAS NO IMPACT ON THE MEDIAN TERM OUTCOME OF PATIENTS WITH INTERMEDIATE RISK DIFFERENTIATED THYROID CANCER
    Matrone, Antonio
    Gambale, Carla
    Torregrossa, Liborio
    Piaggi, Paolo
    Bianchi, Francesca
    Valerio, Laura
    Viola, David
    Agate, Laura
    Molinaro, Eleonora
    Materazzi, Gabriele
    Basolo, Fulvio
    Vitti, Paolo
    Elisei, Rossella
    ENDOCRINE PRACTICE, 2020, 26 (01) : 58 - 71
  • [48] DERMATOMYOSITIS ASSOCIATED WITH THYROID-CANCER - FAVORABLE COURSE AFTER I-131 IRRADIATION
    ARCHAMBEAUDMOUVEROUX, F
    BERNARD, P
    LAROUMAGNE, G
    DEJAX, C
    VALLAT, JM
    PRESSE MEDICALE, 1986, 15 (38): : 1928 - 1928
  • [49] Stimulated thyroglobulin ( TG) prior to [131I] therapy (RAIT) in patients with differentiated thyroid cancer (DTC) as a predictive factor of recurrence
    Nunez-Munoz, R.
    Ortega, Y. Carreres
    Sarmiento, M. A. Astudillo
    Jorge, R. Valverde
    Fuentes, A. Pena
    Subirats, J. Genolla
    Sandi, J. Santamaria
    Molinuevo, M. Badiola
    Ortiz de Zarate, E. Rodeno
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2022, 49 (SUPPL 1) : S586 - S586
  • [50] Risk of second primary malignancies (SPM) following radioactive I-131 (RAI) therapy in patients with differentiated thyroid cancer (DTC)
    Ansari, Aiysha
    Kulkarni, Kanchan
    Van Nostrand, Douglas
    Khorjekarand, Gauri
    Garcia, Carlos
    JOURNAL OF NUCLEAR MEDICINE, 2010, 51
12345